Displaying drugs 76 - 100 of 12632 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| CG0070 | Not Available |  | Investigated for use/treatment in bladder cancer. | Not Available |
| AZD3409 | Not Available |  | For the treatment of solid tumors. | Not Available |
| XL844 | Not Available |  | Investigated for use/treatment in cancer/tumors (unspecified) and solid tumors. | Not Available |
| AZD 3355 | Not Available |  | Investigated for use/treatment in gastroesophageal reflux disease (GERD). | GABA-A Receptor Agonists / Gastrointestinal Agents |
| Polifeprosan 20 | Not Annotated |  | Polifeprosan 20 is under investigation in clinical trial NCT00003878 (Carmustine Implants in Treating Patients With Brain Metastases). | Not Annotated |
| Conjugated estrogens | Not Available |  | A mixture of estrogens used in estrogen replacement therapy for menopause and hypoestrogenism, used in the treatment of various malignancies, and used in the treatment of postmenopausal osteoporosis. | Natural and Semisynthetic Estrogens, Plain |
| CAD106 | Not Available |  | Investigated for use/treatment in alzheimer's disease. | Not Available |
| alpha-Tocopherol acetate | Not Available |  | A form of vitamin E used to treat and prevent vitamin deficiencies. | Antioxidants / Tocopherols / Vitamins |
| JNJ-17216498 | Not Annotated |  | JNJ-17216498 is a histamine receptor H3 antagonist developed by Johnson and Johnson for the treatment of narcolepsy. | Not Annotated |
| TST10088 | Not Available |  | Investigated for use/treatment in solid tumors. | Not Available |
| GTI-2501 | Not Available |  | Investigated for use/treatment in prostate cancer and solid tumors. | Nucleic Acids, Nucleotides, and Nucleosides / Nucleotides / Polynucleotides |
| NP-50301 | Not Available |  | Investigated for use/treatment in eye disorders/infections. | Not Available |
| LS11 | Not Available |  | Investigated for use/treatment in macular degeneration. | Not Available |
| Lecithin | Not Annotated |  | Fatty substances commonly found in nutritional supplements. | Glycerophospholipids / Phosphatidylcholines / Plant Extracts / Surface-Active Agents |
| DDP-200 | Not Available |  | Investigated for use/treatment in urinary incontinence. | Not Available |
| Alginic acid | Not Available |  | Indicated for the management of gastric reflux, reflux oesophagitis, hiatus hernia, heartburn (including heartburn of pregnancy) and similar gastric distress . | Alginates / Glucuronates / Hexuronic Acids / Polysaccharides |
| Dimethicone 410 | Not Available |  | Dimethicone is approved as a transdermal drug delivery system. Dimethicone 410 is part of the simethicone element in Dow Corning Q7-2242 LVA which is an antifoam.[L2163, L2166] Some OTC's containing... | Not Available |
| Sodium phosphate, monobasic, unspecified form | Not Available |  | An osmotic laxative used to cleanse the colon before a colonoscopy. | Osmotic Laxatives |
| Olafertinib | Not Annotated |  | Not Annotated | Not Annotated |
| 2-O, 3-O desulfated heparin | Not Annotated |  | Not Annotated | Not Annotated |
| KTX-1001 | Not Annotated |  | Not Annotated | Not Annotated |
| BBT-877 | Not Annotated |  | BBT-877 is an autotaxin enzyme inhibitor being investigated for the treatment of fibrotic diseases, such as idiopathic pulmonary fibrosis. | Not Annotated |
| RTA 744 | Not Available |  | Investigated for use/treatment in brain cancer. | Not Available |
| TAK-751S | Not Available |  | Investigated for use/treatment in pediatric indications and infectious and parasitic disease (unspecified). | Carbohydrates / Oligosaccharides / Polysaccharides |
| Tolu balsam | Not Annotated |  | Not Annotated | Standardized Chemical Allergen |
Displaying drugs 76 - 100 of 12632 in total